HCPCS code J9052: Carmustine injection, per 100 mg2026 Medicare rate & RVUs in Missouri
Reports Accord carmustine injection used in cancer treatment, with each HCPCS unit representing 100 mg of the drug administered.
CMS doesn’t publish an office rate for J9052 in Missouri.
Medicare allowed amount for participating (non-QP) physicians, before deductible, coinsurance and claim adjustments. Not a patient’s bill or a hospital charge.
Your location
On this page 9 sections
What J9052 covers
J9052 identifies Accord carmustine injection, an intravenous antineoplastic drug used in treatment of cancers including brain tumors and lymphomas. Oncology practices and hospital outpatient departments may report it when this specific carmustine product is administered as part of a treatment regimen. Select the code for the product actually furnished; J9052 is identified as not therapeutically equivalent to J9050, so the two product codes are not interchangeable simply because both contain carmustine.
CMS excludes J9052 from the physician fee schedule under status E. When Medicare covers the drug, it is treated as a Part B drug and generally priced through CMS quarterly Average Sales Price files; special Medicare coverage instructions apply. One HCPCS unit represents 100 mg, so report units based on the amount administered. The drug code identifies the medication, while the chemotherapy administration service is reported separately when applicable.
This summary was written with AI assistance from CMS physician fee schedule data and checked against the CMS billing rules shown here. Rates on this page come directly from CMS files.
Where J9052 pays more and less in Missouri
The same RVUs, adjusted for each area’s costs. Open a locality for its calculation, history and nearby areas.
| Payment locality | Office | Facility |
|---|---|---|
| Metropolitan Kansas City, MO | Unavailable | Unavailable |
| Metropolitan St. Louis, MO | Unavailable | Unavailable |
| Rest of Missouri | Unavailable | Unavailable |
How the J9052 rate is calculated
Each of J9052’s three RVUs is multiplied by a geographic index (GPCI) for the payment locality, added up, and multiplied by the conversion factor. Drag the indexes or enter a ZIP to see what moves the rate.
How the rate is built · J9052
RVUs × geographic indexes × conversion factor
Work0.00
0.00 RVUs× 1.000 GPCI
Practice expense0.00
0.00 RVUs× 1.000 GPCI
Malpractice0.00
0.00 RVUs× 1.000 GPCI
Adjusted RVUs
0.0000
Conversion factor
$33.4009
Medicare rate
$0.00
Every GPCI starts at 1.000, the national rate. Enter a ZIP or drag a slider.
Payment rules and modifiers for J9052
J9052 has no global surgery period, no multiple-procedure, bilateral or assistant-at-surgery adjustment, and no professional/technical split. What changes the payment is where the service happens: the place of service on the claim decides whether Medicare pays the office or the facility rate.
Place of service · J9052
Which rate does Medicare pay?
The POS code on the claim line (CMS-1500 box 24B).
POS 11 · non-facility rate · national
—
J9052 isn’t priced in this setting.
J9052 compared with similar codes
Compare codes · National
4 codes, side by side
How to choose
- J9050Carmustine injectionPer 100 mg
- Both codes identify carmustine, but J9052 is for the Accord product and is identified as not therapeutically equivalent to J9050. Choose according to the product furnished.
- J9045CarboplatinPer 50 mg
- J9045 identifies carboplatin, a different antineoplastic drug. Use J9052 for the Accord carmustine product, not for carboplatin.
- J9040Bleomycin injectionPer 15 units
- J9040 identifies bleomycin sulfate, not carmustine. The drug administered determines which code applies.
J9052 billing questions
When should a biller use J9052 instead of J9050?
Use J9052 for the Accord carmustine product identified by this code. It is specifically distinguished from J9050 as not therapeutically equivalent, so code the product furnished rather than treating the codes as interchangeable.
How many milligrams does one unit represent?
One unit represents 100 mg of carmustine. Calculate the number of units from the amount administered.
Is J9052 the chemotherapy administration service?
No. J9052 reports the drug; an applicable chemotherapy administration service, such as CPT 96413 for an initial intravenous infusion, is a separate service.
How does Medicare treat J9052?
CMS assigns status E, excluding it from the physician fee schedule. When covered, it is a Part B drug generally priced through CMS quarterly ASP files, and special Medicare coverage instructions apply.
Is carmustine given intravenously?
Yes. J9052 is for carmustine injection administered intravenously in cancer treatment.
Where these rates come from
FeeBase calculates base physician payments from CMS work, practice-expense and malpractice RVUs, adjusted by each locality’s geographic indexes and the conversion factor. Services without a published rate are labeled, never given a made-up amount. Amounts are Medicare allowed amounts before claim adjustments: not a patient’s bill or a commercial rate.
CMS RVU26D · effective Oct 1, 2026 through the day before Jan 1, 2027
Fee sheets · Coming soon
Put J9052 and the rest of your codes on one sheet
Your codes at your locality, with payer contracts beside Medicare.
Join the waitlist